Chronic Obstructive Pulmonary Disease: Emerging Medical Therapies
Author: MacIntyre, Neil R.
Source: Respiratory Care, Volume 49, Number 1, January 2004 , pp. 64-71(8)
Publisher: The Journal Respiratory Care Company
Abstract:As many as 10 million Americans have chronic obstructive pulmonary disease and as a consequence experience disabling symptoms, high cost of care, and substantial mortality. Several new approaches are being investigated for possible benefit in managing (or even reversing) chronic obstructive pulmonary disease. This article reviews 4 new approaches that are either in or close to phase III trials: long-acting bronchodilators, phosphodiesterase-4 inhibitors, vasodilators, and retinoids. Of those tiotropium appears to be the closest to receiving clinical approval in the United States. The risk/benefit ratio and the cost-effectiveness of the other compounds are less clear and await additional study.
Document Type: Research article
Publication date: 2004-01-01
- As of January 1, 2013, Respiratory Care content will no longer be hosted on ingentaconnect. Please contact the publisher at email@example.com for information on how to continue access to this title.
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Membership Information
- Information for Advertisers
- Clinical Practice Guidelines
- Past OPEN FORUM Abstracts
- ingentaconnect is not responsible for the content or availability of external websites